AIM ImmunoTech Inc. (AIM) Stock price, Description, News & Info

#Thinksabio latest news

AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval